Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Swixx BioPharma
Baar, Switzerlandswixxbiopharma.com ↗
- Ownership
- Private
- Employees
- ~1600
- Development stage
- Commercial
01
Overview
Swixx BioPharma is a specialized distributor and commercialization partner for pharmaceutical companies in Central & Eastern Europe, CIS/Eurasia, MENA, and Latin America. The company achieved over €900 million in sales in 2023 and was recognized by the Financial Times as one of Europe's fastest-growing companies with a 70.6% CAGR in 2024.
- Therapeutic areas
- OncologyInfectious DiseasesRare DiseasesOther
- Industry
- Consulting
02
Partnerships
Beyond the preview
Go deeper on Swixx BioPharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Swixx BioPharma.